Loading…

Danish biotech start-up 21st.Bio has filed an EU Novel Food application for precision-fermented bovine beta-lactoglobulin, a milk protein produced without animal inputs. The product already has US regulatory approval from October 2025.
If approved, precision-fermented BLG could add supply of dairy protein in Europe, where whey protein is constrained, which may ease pressure on whey prices over time. Approval is still years away, so the near-term price impact is limited.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.